CSE/ABRT (CSE/ABRT)

Canadian Securities Exchange: CSE/ABRT · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	372.1K
Net income (ttm)	-2.3M
EPS (ttm)	-CA$0.04
Shares out	74.4M
Volume	1,000
Beta	2.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -2.3M
EPS (ttm): -CA$0.04
Market cap: 372.1K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROICn/a

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/ABRT indicators

Market & fundamental data

Available fields

125

Groups with data

Currency

CAD

Showing 125 of 125 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Enterprise value	CAD 382,086
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2023-09-30
First seen	2026-05-10
Fiscal year end	December
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA0127841041
Last earnings date	2025-11-28
Last refreshed	2026-10-29
Market cap	CAD 372,066
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2024-07-16
Symbol	cse/ABRT
Website	https://albertlabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-709.22%
FCF / EV yield	-128.9%
FCF yield	-132.37%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-425.88%
ROCE	524.38%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	5
Net income growth quarters	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD 20,057
Depreciation and amortization	CAD 16,940
EBIT	CAD -2.3M
EBITDA	CAD -2.3M
EPS	CAD -0.04
FCF per share	CAD -0.01
Financing cash flow	CAD 340,496
Free cash flow	CAD -492,499
Free cash flow minus SBC	CAD -2.1M
Investing cash flow	CAD 20,057
Net borrowing	CAD 9,980
Net cash flow	CAD -105,355
Net income	CAD -2.3M
Operating cash flow minus SBC	CAD -2.1M
Operating income	CAD -2.3M
Stock-based compensation	CAD 1.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD -0.01
Interest coverage	-15,489.21
Long-term assets	CAD 51,794
Long-term liabilities	CAD 0
Net cash (debt)	CAD -10,019
Net cash / market cap	-2.69%
Piotroski F-Score	1
Property, plant and equipment	CAD 51,794
Shareholders' equity	CAD -443,073
Tangible book value	CAD -443,073
Tangible book value per share	CAD -0.01
Total assets	CAD 64,625
Total cash	CAD 111
Total debt	CAD 10,130
Total liabilities	CAD 507,698
WACC	15.29%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 12,831
Current liabilities	CAD 507,698
Current ratio	0.03
Net working capital	CAD -484,848
Quick ratio	0
Working capital	CAD -494,867

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-16.76%
Shareholder yield	-16.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.02
1D price change	0%
1M price change	-50%
1M total return	-50%
1W price change	-66.67%
1W total return	-66.67%
1Y price change	-83.33%
1Y return CAGR	-83.27%
1Y total return	-83.33%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.04
3M price change	-66.67%
3M total return	-66.67%
50-day SMA	CAD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.04
52-week high date	2023-07-17
52-week low	CAD 0.01
52-week low date	2024-07-16
6M price change	-66.67%
6M total return	-66.67%
All-time high	CAD 0.40
All-time high date	2022-10-20
All-time low	CAD 0.01
All-time low date	2023-10-27
Average true range (ATR)	CAD 0.00
Average volume	23.8K
Beta (1Y)	0
Beta (2Y)	0
Beta (5Y)	2.08
Change from 52-week high	-87.5%
Change from 52-week low	0%
Change from all-time high	-98.75%
Change from all-time low	0%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 5
High price	CAD 0.01
Low price	CAD 0.01
Monthly RSI	31.92
Open price	CAD 0.01
Previous close	CAD 0.01
Price vs 150-day SMA	-79.84%
Price vs 20-day SMA	-58.33%
Price vs 200-day SMA	-86.98%
Price vs 50-day SMA	-60.94%
Relative volume	0.04
RSI	39.7
Sharpe ratio	1
Sortino ratio	3.43
Volume	1K
Weekly RSI	35.39
YTD price change	-50%
YTD total return	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0%
Shares outstanding	74.4M

Deeper analysis on CSE/ABRT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/ABRT report

Is a complete CSE/ABRT research report available?

No complete published report is available for cse/ABRT (CSE/ABRT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/ABRT (CSE/ABRT)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/ABRT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/ABRT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/ABRT

Frequently asked questions